Advertisement

Sexual Perception in Spanish Female Breast Cancer Survivors. Cross-Sectional Survey

Published:October 20, 2022DOI:https://doi.org/10.1016/j.clbc.2022.10.011

      Highlights

      • A low percentage of women resorted to or requested information and treatment from a pelvic physical therapist.
      • It seems that there is a negative correlation between the presence of pain during sexual intercourse and its effect on sexual life.
      • Surviving women of breast cancer have little knowledge about the role of physiotherapy in the conservative treatment of sexual dysfunction that can appear as a side effect of the treatments received.

      ABSTRACT

      Background

      The aim was to assess sexual perception in female breast cancer survivors and establish if women presenting with sexual dysfunctions symptoms receive pelvic floor physiotherapy or request information on treatment.

      Methods

      Cross-sectional survey carried out between January and March 2021. An online survey designed by the authors was structured in 3 dimensions: demographic and anthropometric data, medical data and sexual perception data. An open format survey with 23 questions available to any website visitor. The survey followed the CHERRIES guidelines. The study included 130 women who fulfilled the inclusion criteria.

      Results

      The presence of pain during sexual activity was reported in 56.92% of cases. Specifically, 40.8% reported superficial dyspareunia, which is most commonly expressed by women as a “stinging pain.” Surprisingly, only 4.6% of the women had received any type of pelvic floor physiotherapy treatment or had sought information.

      Conclusions

      Women breast cancer survivors have a negative perception of their sexuality. In addition, there is a lack of knowledge about the role of physiotherapy in sexual dysfunction, and only a small percentage of women received pelvic floor treatment or information to address their sexual dysfunction.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Breast Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Harbeck N
        • Penault-Llorca F
        • Cortes J
        • et al.
        Breast cancer.
        Nat Rev Dis Primers. 2019; 5: 66https://doi.org/10.1038/s41572-019-0111-2
        • Lemanne D
        • Maizes V.
        Advising women undergoing treatment for breast cancer: a narrative review.
        J Altern Complement Med. 2018; 24: 902-909https://doi.org/10.1089/acm.2018.0150
        • Shapiro CL.
        Cancer survivorship.
        N Engl J Med. 2018; 379: 2438-2450https://doi.org/10.1056/NEJMra1712502
        • Sociedad española de oncología médica
        Estimaciones de la incidencia del cáncer en España, 2022.
        Red Esp Regist Cáncer REDECAN. 2022; (ISBN: 978-84-09-38029-9)
      1. Cancer today. World Health Organization. Available at: https://gco.iarc.fr/today/home. [accessed 1 March 2022]

      2. Sociedad española de oncología médica. Las cifras del 2021 cáncer en España. 2021. ISBN: 978-84-09-27704-9

        • Hashim D
        • Boffetta P
        • La Vecchia C
        • et al.
        The global decrease in cancer mortality: trends and disparities.
        Ann Oncol. 2016; 27: 926-933https://doi.org/10.1093/annonc/mdw027
        • Soldera SV
        • Ennis M
        • Lohmann AE
        • Goodwin PJ.
        Sexual health in long-term breast cancer survivors.
        Breast Cancer Res Treat. 2018; 172: 159-166https://doi.org/10.1007/s10549-018-4894-8
        • Ribi K
        • Luo W
        • Walley BA
        • et al.
        Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy.
        Breast Cancer Res Treat. 2020; 181: 347-359https://doi.org/10.1007/s10549-020-05622-5
        • Crean-Tate KK
        • Faubion SS
        • Pederson HJ
        • Vencill JA
        • Batur P.
        Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy.
        Am J Obstet Gynecol. 2020; 222: 103-113https://doi.org/10.1016/j.ajog.2019.08.043
        • Cobo-Cuenca AI
        • Martín-Espinosa NM
        • Sampietro-Crespo A
        • Rodríguez-Borrego MA
        • Carmona-Torres JM.
        Sexual dysfunction in Spanish women with breast cancer.
        PLoS One. 2018; 13e0203151https://doi.org/10.1371/journal.pone.0203151
        • Santen RJ
        • Stuenkel CA
        • Davis SR
        • Pinkerton JV
        • Gompel A
        • Lumsden MA.
        Managing menopausal symptoms and associated clinical issues in breast cancer survivors.
        J Clin Endocrinol Metab. 2017; 102: 3647-3661https://doi.org/10.1210/jc.2017-01138
        • Boquiren VM
        • Esplen MJ
        • Wong J
        • Toner B
        • Warner E
        • Malik N.
        Sexual functioning in breast cancer survivors experiencing body image disturbance.
        Psychooncology. 2016; 25: 66-76https://doi.org/10.1002/pon.3819
        • Mendoza N
        • Carrión R
        • Mendoza-Huertas L
        • Jurado AR.
        Efficacy and safety of treatments to improve dyspareunia in breast cancer survivors: a systematic review.
        Breast Care (Basel). 2020; 15: 599-607https://doi.org/10.1159/000506148
        • Streicher L
        • Simon JA.
        Sexual function post-breast cancer. En: Gradishar WJ, editor. Optimizing Breast Cancer Management. Springer International Publishing.
        Cancer Treatment and Research. 2018; 273: 167-189https://doi.org/10.1007/978-3-319-70197-4_11
        • Sousa M
        • Peate M
        • Lewis C
        • et al.
        Exploring knowledge, attitudes and experience of genitourinary symptoms in women with early breast cancer on adjuvant endocrine therapy.
        Eur J Cancer Care (Engl). 2018; 27: e12820https://doi.org/10.1111/ecc.12820
        • Stabile C
        • Goldfarb S
        • Baser RE
        • et al.
        Sexual health needs and educational intervention preferences for women with cancer.
        Breast Cancer Res Treat. 2017; 165: 77-84https://doi.org/10.1007/s10549-017-4305-6
        • Kent EE
        • Arora NK
        • Rowland JH
        • et al.
        Health information needs and health-related quality of life in a diverse population of long-term cancer survivors.
        Patient Educ Couns. 2012; 89: 345-352https://doi.org/10.1016/j.pec.2012.08.014
        • Sporn NJ
        • Smith KB
        • Pirl WF
        • Lennes IT
        • Hyland KA
        • Park ER.
        Sexual health communication between cancer survivors and providers: how frequently does it occur and which providers are preferred?.
        Psychooncology. 2015; 24: 1167-1173https://doi.org/10.1002/pon.3736
        • Wallace SL
        • Miller LD
        • Mishra K.
        Pelvic floor physical therapy in the treatment of pelvic floor dysfunction in women.
        Curr Opin Obstet Gynecol. 2019; 31: 485-493https://doi.org/10.1097/GCO.0000000000000584
        • Berghmans B.
        Physiotherapy for pelvic pain and female sexual dysfunction: an untapped resource.
        Int Urogynecol J. 2018; 29: 631-638https://doi.org/10.1007/s00192-017-3536-8
        • López-Rodríguez JA.
        Declaración de la iniciativa CHERRIES: adaptación al castellano de directrices para la comunicación de resultados de cuestionarios y encuestas online [Improving the quality of Spanish web surveys: Spanish adaptation of the checklist for reporting results of internet e-surveys (CHERRIES) to the Spanish context].
        Aten Primaria. 2019; 51 (Spanish): 586-589https://doi.org/10.1016/j.aprim.2019.03.005
        • World Medical Association Declaration of Helsinki
        Ethical principles for medical research involving human subjects.
        JAMA. 2013; 310: 2191-2194https://doi.org/10.1001/jama.2013.281053
        • Chen J
        • Geng L
        • Song X
        • Li H
        • Giordan N
        • Liao Q.
        Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial.
        J Sex Med. 2013; 10: 1575-1584https://doi.org/10.1111/jsm.12125
        • Lester J
        • Pahouja G
        • Andersen B
        • Lustberg M.
        Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue.
        J Pers Med. 2015; 5: 50-66https://doi.org/10.3390/jpm5020050
        • Sussman TA
        • Kruse ML
        • Thacker HL
        • Abraham J.
        Managing genitourinary syndrome of menopause in breast cancer survivors receiving endocrine therapy.
        J Oncol Pract. 2019; 15: 363-370https://doi.org/10.1200/JOP.18.00710
        • Greendale GA
        • Sternfeld B
        • Huang M
        • et al.
        Changes in body composition and weight during the menopause transition.
        JCI Insight. 2019; 4e124865https://doi.org/10.1172/jci.insight.124865
        • Chan DSM
        • Vieira AR
        • Aune D
        • et al.
        Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies.
        Ann Oncol. 2014; 25: 1901-1914https://doi.org/10.1093/annonc/mdu042
        • Miaja M
        • Platas A
        • Martinez-Cannon BA.
        Psychological impact of alterations in sexuality, fertility, and body image in young breast cancer patients and their partners.
        Rev Invest Clin. 2017; 69: 111https://doi.org/10.24875/ric.17002279
        • Gandhi C
        • Butler E
        • Pesek S
        • et al.
        Sexual dysfunction in breast cancer survivors: is it surgical modality or adjuvant therapy?.
        Am J Clin Oncol. 2019; 42: 500-506https://doi.org/10.1097/COC.0000000000000552